Measurement of disease activity in ulcerative colitis: Interobserver agreement a

2011-06-21 MedSci原创 MedSci原创

Thia, K. T., E. V. Loftus, Jr., et al. (2011). "Measurement of disease activity in ulcerative colitis: Interobserver agreement and predictors of severity." Inflamm Bowel Dis 17(6): 1257-1264. BACKGRO

Thia, K. T., E. V. Loftus, Jr., et al. (2011). "Measurement of disease activity in ulcerative colitis: Interobserver agreement and predictors of severity." Inflamm Bowel Dis 17(6): 1257-1264.

BACKGROUND: Endoscopic evaluation plays a pivotal role in the assessment of treatment response in ulcerative colitis (UC). This study aimed to determine the interobserver agreement (IOA) for assessment of mucosal lesions, and to determine lesions predictive of global assessment of endoscopic severity (GAES). METHODS: Fifty-one UC patients had digital videorecording of their colonoscopic examinations, edited into videoclips representative of five colonic segments (rectum, sigmoid, descending, transverse, ascending/cecum). Seven gastroenterologists specializing in inflammatory bowel disease (IBD) independently and blindly rated individual lesions and endoscopic severity for each segment and globally. Edema, erythema, stricture, loss of haustral folds, rigidity, and pseudopolyps were scored as absent or present while vascular pattern, granularity, ulceration, and bleeding-friability were scored using a predefined severity scale. The GAES was based on a 4-point scale and a 10-cm visual analog scale (VAS). The IOA among raters was estimated using Lin's concordance correlation coefficient (CCC). Strength of agreement was categorized as excellent (0.81-1.00), good (0.61-0.80), moderate (0.41-0.60), and fair (0.21-0.40). Linear regression analysis was used to identify lesions predictive of overall endoscopic severity and develop a scoring system for clinical use. RESULTS: Granularity, vascular pattern, ulceration, bleeding/friability, and pseudopolyps had good IOA in most segments. There was excellent agreement for VAS and good agreement for GAES and the VAS was significantly associated with GAES (P < 0.001). Granularity, vascular pattern, ulceration, and bleeding-friability were significant predictors of overall endoscopic severity. CONCLUSIONS: Granularity, vascular pattern, ulceration, and bleeding-friability demonstrated good reproducibility and were predictors of the GAES in UC patients. (Inflamm Bowel Dis 2011).

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1738732, encodeId=77fd1e3873227, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6913, encryptionId=6e566913df, topicName=ERA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e36234488643, createdName=124988c7m106暂无昵称, createdTime=Fri May 25 10:37:00 CST 2012, time=2012-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1752212, encodeId=8f441e5221247, content=<a href='/topic/show?id=28a915303ec' target=_blank style='color:#2F92EE;'>#REM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15303, encryptionId=28a915303ec, topicName=REM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78bc36479935, createdName=tongyongming, createdTime=Sat Nov 26 12:37:00 CST 2011, time=2011-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2011766, encodeId=ebab2011e6678, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Mon Apr 23 22:37:00 CST 2012, time=2012-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1390049, encodeId=891a139004985, content=<a href='/topic/show?id=f90e4994ac' target=_blank style='color:#2F92EE;'>#colitis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4994, encryptionId=f90e4994ac, topicName=colitis)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cb02500048, createdName=ms6832696159214430, createdTime=Thu Jun 23 04:37:00 CST 2011, time=2011-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455215, encodeId=4c41145521533, content=<a href='/topic/show?id=8aa718110d1' target=_blank style='color:#2F92EE;'>#ulcerative#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18110, encryptionId=8aa718110d1, topicName=ulcerative)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15c35641099, createdName=zjubiostat, createdTime=Thu Jun 23 04:37:00 CST 2011, time=2011-06-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1738732, encodeId=77fd1e3873227, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6913, encryptionId=6e566913df, topicName=ERA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e36234488643, createdName=124988c7m106暂无昵称, createdTime=Fri May 25 10:37:00 CST 2012, time=2012-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1752212, encodeId=8f441e5221247, content=<a href='/topic/show?id=28a915303ec' target=_blank style='color:#2F92EE;'>#REM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15303, encryptionId=28a915303ec, topicName=REM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78bc36479935, createdName=tongyongming, createdTime=Sat Nov 26 12:37:00 CST 2011, time=2011-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2011766, encodeId=ebab2011e6678, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Mon Apr 23 22:37:00 CST 2012, time=2012-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1390049, encodeId=891a139004985, content=<a href='/topic/show?id=f90e4994ac' target=_blank style='color:#2F92EE;'>#colitis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4994, encryptionId=f90e4994ac, topicName=colitis)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cb02500048, createdName=ms6832696159214430, createdTime=Thu Jun 23 04:37:00 CST 2011, time=2011-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455215, encodeId=4c41145521533, content=<a href='/topic/show?id=8aa718110d1' target=_blank style='color:#2F92EE;'>#ulcerative#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18110, encryptionId=8aa718110d1, topicName=ulcerative)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15c35641099, createdName=zjubiostat, createdTime=Thu Jun 23 04:37:00 CST 2011, time=2011-06-23, status=1, ipAttribution=)]
    2011-11-26 tongyongming
  3. [GetPortalCommentsPageByObjectIdResponse(id=1738732, encodeId=77fd1e3873227, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6913, encryptionId=6e566913df, topicName=ERA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e36234488643, createdName=124988c7m106暂无昵称, createdTime=Fri May 25 10:37:00 CST 2012, time=2012-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1752212, encodeId=8f441e5221247, content=<a href='/topic/show?id=28a915303ec' target=_blank style='color:#2F92EE;'>#REM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15303, encryptionId=28a915303ec, topicName=REM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78bc36479935, createdName=tongyongming, createdTime=Sat Nov 26 12:37:00 CST 2011, time=2011-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2011766, encodeId=ebab2011e6678, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Mon Apr 23 22:37:00 CST 2012, time=2012-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1390049, encodeId=891a139004985, content=<a href='/topic/show?id=f90e4994ac' target=_blank style='color:#2F92EE;'>#colitis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4994, encryptionId=f90e4994ac, topicName=colitis)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cb02500048, createdName=ms6832696159214430, createdTime=Thu Jun 23 04:37:00 CST 2011, time=2011-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455215, encodeId=4c41145521533, content=<a href='/topic/show?id=8aa718110d1' target=_blank style='color:#2F92EE;'>#ulcerative#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18110, encryptionId=8aa718110d1, topicName=ulcerative)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15c35641099, createdName=zjubiostat, createdTime=Thu Jun 23 04:37:00 CST 2011, time=2011-06-23, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1738732, encodeId=77fd1e3873227, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6913, encryptionId=6e566913df, topicName=ERA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e36234488643, createdName=124988c7m106暂无昵称, createdTime=Fri May 25 10:37:00 CST 2012, time=2012-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1752212, encodeId=8f441e5221247, content=<a href='/topic/show?id=28a915303ec' target=_blank style='color:#2F92EE;'>#REM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15303, encryptionId=28a915303ec, topicName=REM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78bc36479935, createdName=tongyongming, createdTime=Sat Nov 26 12:37:00 CST 2011, time=2011-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2011766, encodeId=ebab2011e6678, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Mon Apr 23 22:37:00 CST 2012, time=2012-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1390049, encodeId=891a139004985, content=<a href='/topic/show?id=f90e4994ac' target=_blank style='color:#2F92EE;'>#colitis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4994, encryptionId=f90e4994ac, topicName=colitis)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cb02500048, createdName=ms6832696159214430, createdTime=Thu Jun 23 04:37:00 CST 2011, time=2011-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455215, encodeId=4c41145521533, content=<a href='/topic/show?id=8aa718110d1' target=_blank style='color:#2F92EE;'>#ulcerative#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18110, encryptionId=8aa718110d1, topicName=ulcerative)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15c35641099, createdName=zjubiostat, createdTime=Thu Jun 23 04:37:00 CST 2011, time=2011-06-23, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1738732, encodeId=77fd1e3873227, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6913, encryptionId=6e566913df, topicName=ERA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e36234488643, createdName=124988c7m106暂无昵称, createdTime=Fri May 25 10:37:00 CST 2012, time=2012-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1752212, encodeId=8f441e5221247, content=<a href='/topic/show?id=28a915303ec' target=_blank style='color:#2F92EE;'>#REM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15303, encryptionId=28a915303ec, topicName=REM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78bc36479935, createdName=tongyongming, createdTime=Sat Nov 26 12:37:00 CST 2011, time=2011-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2011766, encodeId=ebab2011e6678, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Mon Apr 23 22:37:00 CST 2012, time=2012-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1390049, encodeId=891a139004985, content=<a href='/topic/show?id=f90e4994ac' target=_blank style='color:#2F92EE;'>#colitis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4994, encryptionId=f90e4994ac, topicName=colitis)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cb02500048, createdName=ms6832696159214430, createdTime=Thu Jun 23 04:37:00 CST 2011, time=2011-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455215, encodeId=4c41145521533, content=<a href='/topic/show?id=8aa718110d1' target=_blank style='color:#2F92EE;'>#ulcerative#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18110, encryptionId=8aa718110d1, topicName=ulcerative)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15c35641099, createdName=zjubiostat, createdTime=Thu Jun 23 04:37:00 CST 2011, time=2011-06-23, status=1, ipAttribution=)]